1. Home
  2. RLAY vs TECH Comparison

RLAY vs TECH Comparison

Compare RLAY & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$8.56

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$59.22

Market Cap

9.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
TECH
Founded
2015
1976
Country
United States
United States
Employees
197
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
9.2B
IPO Year
2020
1989

Fundamental Metrics

Financial Performance
Metric
RLAY
TECH
Price
$8.56
$59.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
14
Target Price
$16.00
$71.23
AVG Volume (30 Days)
2.2M
1.6M
Earning Date
11-06-2025
02-04-2026
Dividend Yield
N/A
0.54%
EPS Growth
N/A
N/A
EPS
N/A
0.49
Revenue
$8,355,000.00
$1,216,732,000.00
Revenue This Year
$20.47
$2.33
Revenue Next Year
N/A
$7.05
P/E Ratio
N/A
$121.67
Revenue Growth
N/A
3.85
52 Week Low
$1.78
$46.01
52 Week High
$9.04
$79.28

Technical Indicators

Market Signals
Indicator
RLAY
TECH
Relative Strength Index (RSI) 63.56 46.70
Support Level $8.13 $56.84
Resistance Level $8.76 $59.58
Average True Range (ATR) 0.49 1.72
MACD 0.01 -0.07
Stochastic Oscillator 73.77 48.24

Price Performance

Historical Comparison
RLAY
TECH

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: